
|Articles|June 1, 2002
Bexarotene tabbed for localized CTCL
New Orleans - Bexarotene gel (Targretin) appears to be both effective and well tolerated for long-term use in early-stage cutaneous T-cell lymphoma, according to a poster presentation at the American Academy of Dermatology annual meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
3
Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia
4
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
5



















